Tag: phase III clinical trial
Alzheimer’s drug lecanemab slows cognitive decline in clinical trial
Eisai, a Japanese pharmaceutical company headquartered in Tokyo, and American multinational Biogen have released the results from their phase III clinical trial of lecanemab,...